Plasma Biomarkers Differentiate Cognitive Impairment in Postmenopausal Women with Insomnia Disorder
Plasma GFAP and p-Tau, with potential incremental contribution from orexin A, may provide exploratory information for identifying cognitive vulnerability in postmenopausal women with insomnia disorder.